These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 26063038)
1. Potential therapeutic benefits stemming from the thermal nature of irreversible electroporation of solid cancers. Heger M; van der Wal AC; Storm G; van Gemert MJ Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):331-3. PubMed ID: 26063038 [No Abstract] [Full Text] [Related]
2. Tissue ablation with irreversible electroporation. Davalos RV; Mir IL; Rubinsky B Ann Biomed Eng; 2005 Feb; 33(2):223-31. PubMed ID: 15771276 [TBL] [Abstract][Full Text] [Related]
3. Synergistic Combination of Electrolysis and Electroporation for Tissue Ablation. Stehling MK; Guenther E; Mikus P; Klein N; Rubinsky L; Rubinsky B PLoS One; 2016; 11(2):e0148317. PubMed ID: 26866693 [TBL] [Abstract][Full Text] [Related]
4. Principles of and advances in percutaneous ablation. Ahmed M; Brace CL; Lee FT; Goldberg SN Radiology; 2011 Feb; 258(2):351-69. PubMed ID: 21273519 [TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation: a new ablation modality--clinical implications. Rubinsky B; Onik G; Mikus P Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation. Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862 [TBL] [Abstract][Full Text] [Related]
7. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Neal RE; Davalos RV Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056 [TBL] [Abstract][Full Text] [Related]
8. Towards optimization of probe placement for radio-frequency ablation. Altrogge I; Kröger T; Preusser T; Büskens C; Pereira PL; Schmidt D; Weihusen A; Peitgen HO Med Image Comput Comput Assist Interv; 2006; 9(Pt 1):486-93. PubMed ID: 17354926 [TBL] [Abstract][Full Text] [Related]
9. Electrical conductivity changes during irreversible electroporation treatment of brain cancer. Garcia PA; Rossmeisl JH; Davalos RV Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416 [TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation for the ablation of liver tumors: are we there yet? Charpentier KP Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618 [TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation for the treatment of cardiac arrhythmias. Sugrue A; Maor E; Ivorra A; Vaidya V; Witt C; Kapa S; Asirvatham S Expert Rev Cardiovasc Ther; 2018 May; 16(5):349-360. PubMed ID: 29595355 [TBL] [Abstract][Full Text] [Related]
12. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience. Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855 [TBL] [Abstract][Full Text] [Related]
13. Non-thermal irreversible electroporation for deep intracranial disorders. Garcia PA; Neal RE; Rossmeisl JH; Davalos RV Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():2743-6. PubMed ID: 21095962 [TBL] [Abstract][Full Text] [Related]
14. Another club in the bag: comment on "Irreversible electroporation for the ablation of liver tumors". Colquhoun SD Arch Surg; 2012 Nov; 147(11):1061. PubMed ID: 23165619 [No Abstract] [Full Text] [Related]
15. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317 [TBL] [Abstract][Full Text] [Related]
16. In vivo results of a new focal tissue ablation technique: irreversible electroporation. Edd JF; Horowitz L; Davalos RV; Mir LM; Rubinsky B IEEE Trans Biomed Eng; 2006 Jul; 53(7):1409-15. PubMed ID: 16830945 [TBL] [Abstract][Full Text] [Related]
17. Irreversible Electroporation of Prostate Cancer: Patient-Specific Pretreatment Simulation by Electric Field Measurement in a 3D Bioprinted Textured Prostate Cancer Model to Achieve Optimal Electroporation Parameters for Image-Guided Focal Ablation. Wendler JJ; Klink F; Seifert S; Fischbach F; Jandrig B; Porsch M; Pech M; Baumunk D; Ricke J; Schostak M; Liehr UB Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1668-1671. PubMed ID: 27256102 [No Abstract] [Full Text] [Related]
18. Anaesthetic management during open and percutaneous irreversible electroporation. Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767 [TBL] [Abstract][Full Text] [Related]
19. Navigation Systems for Treatment Planning and Execution of Percutaneous Irreversible Electroporation. Fuhrmann I; Probst U; Wiggermann P; Beyer L Technol Cancer Res Treat; 2018 Jan; 17():1533033818791792. PubMed ID: 30071779 [TBL] [Abstract][Full Text] [Related]